Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$237.45 USD
+6.44 (2.79%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $237.47 +0.02 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum C VGM
Income Statements
Fiscal Year end for Inspire Medical Systems, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 625 | 408 | 233 | 115 | 82 |
Cost Of Goods | 97 | 66 | 33 | 18 | 14 |
Gross Profit | 528 | 342 | 200 | 98 | 68 |
Selling & Adminstrative & Depr. & Amort Expenses | 569 | 389 | 240 | 154 | 103 |
Income After Depreciation & Amortization | -40 | -48 | -40 | -56 | -35 |
Non-Operating Income | 20 | 5 | 0 | 1 | 4 |
Interest Expense | 0 | 2 | 2 | 2 | 2 |
Pretax Income | -20 | -44 | -42 | -57 | -33 |
Income Taxes | 1 | 1 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -21 | -45 | -42 | -57 | -33 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -21 | -45 | -42 | -57 | -33 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -40 | -46 | -38 | -55 | -35 |
Depreciation & Amortization (Cash Flow) | 0 | 2 | 1 | 1 | 0 |
Income After Depreciation & Amortization | -40 | -48 | -40 | -56 | -35 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.30 | 28.07 | 27.26 | 26.07 | 23.81 |
Diluted EPS Before Non-Recurring Items | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 |
Diluted Net EPS (GAAP) | -0.72 | -1.60 | -1.54 | -2.19 | -1.40 |
Fiscal Year end for Inspire Medical Systems, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 192.51 | 153.30 | 151.09 | 127.90 |
Cost Of Goods | NA | 28.05 | 24.38 | 24.25 | 19.89 |
Gross Profit | NA | 164.45 | 128.92 | 126.84 | 108.01 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 155.16 | 142.39 | 143.44 | 127.51 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 9.29 | -13.47 | -16.60 | -19.50 |
Non-Operating Income | NA | 5.94 | 5.27 | 4.86 | 4.29 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 15.24 | -8.20 | -11.74 | -15.21 |
Income Taxes | NA | 0.48 | 0.34 | 0.21 | 0.22 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 14.76 | -8.54 | -11.95 | -15.42 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 14.76 | -8.54 | -11.95 | -15.42 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 30.24 | 29.37 | 29.23 | 29.09 |
Diluted EPS Before Non-Recurring Items | NA | 0.49 | -0.29 | -0.41 | -0.53 |
Diluted Net EPS (GAAP) | NA | 0.51 | -0.29 | -0.41 | -0.53 |